Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1123-1136

  Thankavel, Krishnan ^a   Madison, Bereneice ^b   Ikeda, Teruo ^c   Malaviya, Ravi ^a   Shah, Ankur H ^a   Arumugam, Prabhu M ^a   Abraham, Soman N ^a,d  

^a BARNES JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c AZABU UNIVERSITY   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial adhesion; FimH; Type 1 fimbriae; Urinary tract infections; Vaccine

Indexed keywords

ADHESIN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FIMBRIA; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; URINARY TRACT INFECTION;

EID: 0030924003     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119623     Document Type: Article

References (71)

1. Svanborg, E.C., and P. de Man. 1987. Bacterial virulence in urinary tract infection. Infect. Dis. Clin. N. Am. 1:731-750.
2. Johnson, J.R. 1991. Virulence factors in Escherichia coli Urinary Tract Infection. Clin. Microbiol. Rev. 4:80-128.
3. Hagberg, L., U. Jodal, T.K. Korhonen, and C.E. Svanborg. 1981. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect. Immun. 31:564-574.
4. Reid, G., and S.D. Sobel. 1987. Bacterial adherence in the pathogenesis of urinary tract infections: a review. Rev. Infect. Dis. 9:470-487.
5. Silverblatt, F., and L.S. Cohen. 1979. Anti-pili antibodies afford protection against experimental ascending pyelonephritis. J. Clin. Invest. 64:333-336.
6. Abraham, S.N., J.P. Babu, C.S. Giampapa, D.L. Hasty, W.A. Simpson, and E.H. Beachey. 1985. Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect. Immun. 48:625-628.
7. May, A.K., C.A. Bloch, R.G. Sawyer, M.D. Spengler, and T.L. Pruett. 1993. Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae. Infect. Immun. 61:1667-1673.
8. Svanborg, E.C., L.M. Bjursten, R. Hull, S. Hull, K.E. Magnusson, Z. Moldovano, and H. Leffler. 1984. Influence of adhesins on the interaction of Escherichia coli with human phagocytes. Infect. Immun. 44:672-680.
9. Connell, I., W. Agace, P. Klemm, M. Schembri, S. Marild, and C. Svanborg. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA. 93:9827-9832.
10. Malaviya, R., E. Ross, B.A. Jakschik, and S.N. Abraham. 1994. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J. Clin. Invest. 93:1645-1653.
11. Malaviya, R., T. Ikeda, E. Ross, and S.N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (Lond.). 381:77-80.
12. Mundi, H., B. Bjorksten, C. Svanborg, L. Ohman, and C. Dahlgren. 1991. Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect. Immun. 59:4168-4172.
13. Steadman, R., N. Topley, D.E. Jenner, M. Davies, and J.D. Williams. 1988. Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes. Infect. Immun. 56:815-822.
14. Matsumoto, T., Y. Mizunoe, N. Sakamoto, M. Tanaka, and J. Kumazawa. 1990. Increased renal scarring by bacteria with mannose-sensitive pili. Urol. Res. 18:299-303.
15. Clegg, S., and G.F. Gerlach. 1987. Enterobacterial fimbriae. J. Bacteriol. 169:934-9387
16. Gerlach, G.F., S. Clegg, and B. Allen. 1989. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J. Bacteriol. 171:1262-1270.
17. Klemm, P., and G. Christiansen. 1987. Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 208:439-445.
18. Orndorff, P.E., and S. Falkow. 1984. Organization and expression of genes responsible for type 1 piliation in Escherichia coli. J. Bacteriol. 159:736-744.
19. Minon, F.C., S.N. Abraham, E.H. Beachey, and J.D. Gougen. 1986. The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J. Bacteriol. 165:1033-1036.
20. Brinton, C.C. 1965. The structure, function, synthesis and DNA and RNA transport in gram-negative bacteria. Ann. N.Y. Acad. Sci. 27:1003-1054.
21. Maurer, L., and P.E. Orndorff. 1987. Identification and characterization of genes determining receptor binding and pilus length of Escherichia coli type 1 pili. J. Bacteriol. 169:640-645.
22. Harris, S.L., D.A. Elliott, M.C. Blake, L.M. Must, M. Messenger, and P.E. Orndorff. 1990. Isolation and characterization of mutants with lesions affecting pellicle formation and erythrocyte agglutination by type 1 piliated Escherichia coli. J. Bacteriol. 172:6411-6418.
23. Abraham, S.N., D. Sun, J.B. Dale, and E.H. Beachey. 1988. Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (Lond.). 336:682-684.
24. Abraham, S.N., J.D. Goguen, D. Sun, P. Klemm, and E.H. Beachey. 1987. Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J. Bacteriol. 169:5530-5535.
25. Jones, C.H., J.S. Pinkner, R. Roth, J. Heuser, S.N. Abraham, and S.J. Hultgren. 1995. FimH adhesin of type 1 pili is presented in a fibrillar tip structure in the Enterobacteriaceae. Proc. Natl. Acad. Sci. USA. 92:2081-2085.
26. Keith, B.R., L. Maurer, P.A. Spears, and P.E. Orndorff. 1986. Receptor binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli. Infect. Immun. 53:693-696.
27. Tewari, R., J.I. McGregor, T. Ikeda, J.R. Little, S.J. Hultgren, and S.N. Abraham. 1993. Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J. Biol. Chem. 268:3009-3015.
28. Wu, X.R., T.T. Sun, and J.J. Medina. 1996. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc. Natl. Acad. Sci. USA. 93:9630-9635.
29. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd Edition. Cold Spring Harbor Laboratory Press, Plainview, NY. 1.1-7.87.
30. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
31. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc. Natl. Acad. Sci. USA. 76:4350-4352.
32. Jones, C.H., J.S. Pinkner, A.V. Nicholes, L.N. Slonim, S.N. Abraham, and S.J. Hultgren. 1993. FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc. Natl. Acad. Sci. USA. 90:8397-8401.
33. Zeheb, R., and G.A. Orr. 1986. Use of avidin-imino biotin complexes for purifying plasma membrane proteins. Methods Enzymol. 122:87-94.
34. Nhieu, T.V., and R.R. Isberg. 1994. Isolation and identification of eukaryotic receptors promoting bacterial internalization. Methods Enzymol. 236: 307-318.
35. Abraham, S.N., and E.H. Beachey. 1987. Assembly of a chemically synthesized peptide of Escherichia coli type 1 fimbriae into fimbriae-like antigenic structures. J. Bacteriol. 169:2460-2465.
36. Edman, P., and G. Begg. 1967. Automated equipment for sequence determination. Eur. J. Biochem. 1:80-91.
37. Beachey, E.H., and J.M. Seyer. 1986. Protective and nonprotective epitopes of chemically synthesized peptides of type 6 streptococcal M protein. J. Immunol. 136:2287-2292.
38. Keane, W.F., and C.R. Freedman. 1967. Experimental pyelonephritis XIV. Pyelonephritis in normal mice produced by inoculation of Escherichia coli into the bladder lumen during water diuresis. Yale J. Biol. Med. 40:231-237.
39. Haslam, D.B., T. Boren, P. Falk, D. Ilver, A. Chou, Z. Xu, and S. Normark. 1994. The amino terminal domain of the P-pilus adhesin determines receptor specificity. Mol. Microbiol. 14:399-409.
40. Saarela, S., S. Taira, E.L. Nurmiaho-Lassila, A. Makkonen, and M. Rhen. 1995. The Escherichia coli G-fimbrial lectin protein participates both in fimbrial biogenesis and in recognition of the receptor N-acetyl-D-glucosamine. J. Bacteriol. 177:1477-1484.
41. Xu, Z., C.H. Jones, D. Haslam, J.S. Pinkner, K. Dodson, J. Kihlberg, and S.J. Hultgren. 1995. Molecular dissection of PapD interaction with PapG reveals two chaperone-binding sites. Mol. Microbiol. 16:1011-1020.
42. Ponniah, S., R.O. Endres, D.L. Hasty, and S.N. Abraham. 1991. Fragmentation of Escherichia coli type 1 fimbriae exposes cryptic D-mannose-binding sites. J. Bacteriol. 173:4195-4202.
43. Hultgren, S.J., S. Normark, and S.N. Abraham. 1991. Chaperone-assisted assembly and molecular architecture of adhesive pili. Annu. Rev. Microbiol. 45: 383-415.
44. Hansson, L., P. Wallbrandt, J.O. Andersson, M. Bystrom, A. Backman, A. Carlstein, K. Enquist, H. Lonn, C. Otter, and M. Stromqvist. 1995. Carbohydrate specificity of the Escherichia coli P-pilus papG protein is mediated by its N-terminal part. Biochim. Biophys. Acta. 1244:377-383.
45. Wong, W.Y., A.P. Campbell, C. McInnes, B.D. Sykes, W. Paranchych, R.T. Irvine, and R.S. Hodges. 1995. Structure-function analysis of the adherence-binding domain on the pilin of Pseudomonas aeruginosa strains PAK and KB7. Biochemistry. 34:12963-12972.
46. Lee, K.K., H.B. Sheth, W.Y. Wong, R. Sherburne, W. Paranchych, R.S. Hodges, C.A. Lingwood, H. Krivan, and R.T. Irvine. 1994. The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol. Microbiol. 11: 705-713.
47. Buhler, T., H. Hoschutzky, and K. Jann. 1991. Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78:H11: fimbrial morphology and location of the receptor-binding site. Infect. Immun. 59: 3876-3882.
48. Jacobs, A.A., B.H. Simons, and F.K. de Graaf. 1987. The role of lysine-132 and arginine-136 in the receptor-binding domain of the K99 fibrillar subunit. EMBO (Eur. Mol. Biol. Organ.) J. 6:1805-1808.
49. Jacobs, A.A., J. Venema, R. Leeven, H. van Pelt-Heerschap, and F.K. de Graaf. 1987. Inhibition of adhesive activity of K88 fibrillae by peptides derived from the K88 adhesin. J. Bacteriol. 169:735-741.
50. Derewnda, Z., E. Yariv, J.R. Helliwell, A.J. Kalb, E.J. Dodson, M.Z. Papiz, T. Wan, and J. Cambell. 1989. The structure of the saccharide-binding site of concanavalin A. EMBO (Eur. Mol. Biol. Organ.) J. 8:2189-2193.
51. Ezekowitz, A., L.E. Day, and G.A. Herman. 1988. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J. Exp. Med. 167:1034-1046.
52. Madison, B., I. Ofek, S. Clegg, and S.N. Abraham. 1994. Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins. Infect. Immun. 62:843-848.
53. Schmidt, M.A. 1990. Synthetic peptides: prospects for a pili (fimbriae)-based synthetic vaccine. Curr. Top. Microbiol. Immunol. 151:185-204.
54. Pecha, B., D. Low. and P. O'Hanley. 1989. Gal-gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component gal-gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains. J. Clin. Invest. 83:2102-2108.
55. Levine, M.M., R.E. Blak, C.C. Brinton, and M.L. Clements. 1983. Reactogenicity, immunogenicity and efficacy of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand. J. Infect. Dis. 33 (Suppl.):83-95.
56. Brinton, C.C., S.W. Wood, A. Brown, A.M. Labik, J.R. Bryan, S.L. Lee, S.E. Polen, E.C. Tramont, T. Sadoff, and W. Zollinger. 1982. The development of neisserial pilus vaccine for gonorrhea and meningococcal meningitis. Semin. Infect. Dis. 4:140-159.
57. Gerlach, G.F., and S. Clegg. 1988. Characterization of two genes encoding antigenically distinct type 1 fimbriae of Klebsiella pneumoniae. Gene. (Amst.). 64:2321-2340.
58. Adegbola, R.A., and D.C. Old. 1987. Antigenic relationships among type-1 fimbriae of Enterobacteriaceae revealed by immuno-electron microscopy. J. Med. Microbiol. 24:21-28.
59. Silverblatt, F., R. Weinstein, and P. Rene. 1982. Protection against experimental pyelonephritis by antibody to pili. Scand. J. Infect. Dis. 33 (Suppl.): 79-82.
60. Rene, P., M. Dinolfo, and F.J. Silverblatt. 1982. Serum and urogenital antibody responses to Escherichia coli pili in cystitis. Infect. Immun. 38:542-547.
61. O'Hanley, P., D. Lark, S. Falkow, and G. Schoolnik. 1985. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J. Clin. Invest. 75:347-360.
62. Turner, M.W., and D.S. Rowe. 1967. Antibodies of IgA and IgG class in normal human urine. Immunology. 12:689-699.
63. Thapar, M.A., E.L. Parr, J.J. Bozzola, and M.B. Parr. 1991. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine. 9:129-133.
64. Holmgren, J., A.M. Svennerholm, O. Ouchterlony, A. Anderson, G. Walletstrom, and U. Westerberg-Berndtsson. 1975. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enterai and parenteral immunization. Infect. Immun. 12:1331-1340.
65. Mattsby-Baltzer, I., L.A. Hanson, S. Olling, and B. Kaijser. 1982. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli. Infect. Immun. 35:647-655.
66. Feng, L., Y. Xia, T. Yoshimura, and C.B. Wilson. 1995. Modulation of neulrophil influx in glomcrulonephritis in the rat with anti-macrophage inflam-matory protein-2 (MIP-2) antibody. J. Clin. Invest. 95:1009-1017.
67. Kwun, K., J.P. Bramis, M. Haimov, R. Slifkin, S. Glabman, and L. Burrows. 1977. Persistent immunoglobulinuria in irreversible renal allograft rejection in humans. Transplantation (Baltimore). 24:453-457.
68. Abraham, S.N., K. Thankavel, and R. Malaviya. 1997. Mast cells as modulators of host defense in the lung. Front. Biosci. 2:d78-d87.
69. Andriole, V.T., and T.P. Patterson. 1991. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med. Clin. North Am. 75:359-373.
70. Patton, J.P., D.B. Nash, and E. Abrutyn. 1991. Urinary tract infection: economic considerations. Med. Clin. North Am. 75:495-513.
71. Neu, H.C. 1992. The crisis in antibiotic resistance. Science (Wash. DC). 257:1064-1073.